Clicky

ALX Oncology Holdings Inc.(ALXO) News

Date Title
Sep 9 ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference
Sep 4 ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi
Aug 8 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Aug 6 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
Jul 31 ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
Jun 27 Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Jun 27 Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
Jun 26 ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why
Jun 25 Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
Jun 25 Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
Jun 24 Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Jun 21 JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals
Jun 19 Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Jun 18 Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
Jun 17 Insider Buying: CFO Peter Garcia Acquires Shares of ALX Oncology Holdings Inc (ALXO)
Jun 14 Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Jun 11 Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
Jun 10 Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Jun 10 ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
Jun 10 Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review